www.easy-to-use-pharmacy.com
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Stop Smoking
- Surgery
- Urinary Tract
- Women's Health
Generic Norethindrone acetate - Norlutate, Phoslo
Generic Norlutate
Generic Norlutate is used to treat women with abnormal bleeding from the uterus. It is also used to treat women who have stopped having menstrual periods for several months (amenorrhea) but who are not pregnant or going through menopause.
$1.02
Buy now!
Generic Phoslo
Generic PhosLo is used for reducing phosphate levels in late-stage kidney failure.
$0.63
Buy now!
Choose Your language:
- Testimonials
-
I,HAVE RECEIVED THE PRODUCT. I tested it out and my date was tottally satisfied.She wants to get together now twice a week instead of only once.thank you for a life changing product.I ALLREADY enjoy my life but to bring joy to her is a great gift.plus with the dollars we save we can afford to go out. - satisfied customer stewart
Read more »
-
- Watson Confirms Lo Loestrin® Fe Patent Challenge - MarketWatch (press release)
- Watson Confirms Lo Loestrin® Fe Patent ChallengeMarketWatch (press release)
- Lilly, Jaguar Land Rover, Viacom: Intellectual Property - Bloomberg
- Lilly, Jaguar Land Rover, Viacom: Intellectual PropertyBloombergLo Loestrin Fe contains the active ingredients norethindrone acetate and ethinyl estradiol
- Perrigo Announces FDA Final Approval and Launch of OTC Lansoprazole; Watson ... - BioMedReports (subscription)
- Perrigo Announces FDA Final Approval and Launch of OTC Lansoprazole; Watson
- 美股週五盤中震盪走跌 - 鉅亨網
- 美股週五盤中震盪走跌鉅亨網Watson Pharm (WPI) 證實，旗下子公司Watson Laboratories向美國FDA提交下列學名藥上市申請(ANDA)：Norethindrone Acetate/Ethinyl Estradiol與Ethinyl Estradiol、Ferrous Fumarate Tablets,1 mg/0
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
